Ionizable GMO Lipids for Endosomal Escape in RNA LNPs
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current lipid nanoparticle (LNP) systems for RNA delivery face significant challenges in efficiently escaping endosomal compartments due to low cytosolic delivery efficacy, with less than 2% of the RNA payload successfully escaping the endosome, limiting their therapeutic effectiveness.
Innovation Solution
Development of novel ionizable glycerol monooleate (GMO) lipids that combine structural activity with charge-based mechanisms to enhance endosomal escape, increasing the efficiency of RNA delivery by disrupting the endosome membrane through both curvature and charge-based mechanisms.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional ionizable lipids are used in LNP formulation, then the LNP can be taken up by cells via endocytosis, but the LNP remains trapped in endosomal compartments and degrades through the endosome-lysosome acidification pathway with less than 2% escape efficiency
Solution Approach 1:
The patent combines two distinct endosomal escape mechanisms into a single lipid molecule: (1) the ionizable amine group that becomes cationic in acidic endosomes to electrostatically bind and disrupt the endosomal membrane, and (2) the glycerol monooleate (GMO) moiety that forms membrane regions of negative Gaussian curvature to facilitate fusion pore formation. This merging of charge-based and curvature-based mechanisms results in synergistic enhancement of endosomal escape efficiency
Solution Approach 2:
The invention creates a composite lipid structure integrating multiple functional elements: the ionizable amine headgroup, the glycerol backbone, and the oleate fatty acid chain with specific curvature properties. This composite molecular design allows simultaneous exploitation of electrostatic interactions and Gaussian curvature effects to overcome endosomal barriers
2Ease of operation
If LNP enters cells via endocytosis, then cellular uptake is achieved, but the LNP is trapped in endosomes and cannot reach the cytosol before degradation
Solution Approach 1:
The LNP is designed with pre-installed ionizable amine groups that are protonated during endocytic uptake in the acidic endosomal environment, enabling automatic activation of the charge-based disruption mechanism as the LNP enters the endosome. The curvature-inducing GMO structure is pre-positioned to facilitate fusion pore formation when the endosomal membrane is disrupted
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The novel ionizable GMO lipids significantly improve the endosomal escape of RNA payloads, potentially doubling the delivery efficiency of RNA therapeutics to the cytosol, enhancing the therapeutic potential of LNPs for diseases such as COVID-19 and genetic disorders.
Implementation Method 1
They contain tertiary amine that can be protonated in slightly acidic environment in endosome, and the positive charge helps to disrupt the endosome membrane
Implementation Method 2
the positive charge helps to disrupt the endosome membrane and facilitates endosomal escape
Implementation Method 3
Glycerol monooleate (GMO) has been demonstrated by our team to be able to facilitate endosomal escape of lipid nanoparticles (LNPs) due to its unique negative Gaussian curvature
Implementation Method 4
the positive charge helps to disrupt the endosome membrane and facilitates endosomal escape
Data Source
AI summary
RNA therapeutics have the potential to resolve a myriad of genetic diseases. Lipid nanoparticles (LNPs) are among the most successful RNA delivery systems. Expanding their use for the treatment of more genetic diseases hinges on our ability to continuously evolve the design of LNPs with high potency, cellular-specific targeting, and low side effects. Overcoming the difficulty of releasing cargo from endocytosed LNPs remains a significant hurdle. We investigated the fundamental properties of nonviral RNA nanoparticles pertaining to the activation of topological transformations of endosomal membranes and RNA translocation into the cytosol. We showed that, beyond composition, LNP fusogenicity can be prescribed by designing LNP nanostructures that lower the energetic cost of fusion and fusion-pore formation with a target membrane. The inclusion of structurally active lipids leads to enhanced LNP endosomal fusion, fast evasion of endosomal entrapment, and efficacious RNA delivery. For example, a compound of formula I: